Hypopharyngeal cancer mri

Hypopharyngeal cancer Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hypopharyngeal Cancer from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiogram or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hypopharyngeal cancer mri On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hypopharyngeal cancer mri All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hypopharyngeal cancer mri
CDC on Hypopharyngeal cancer mri
Hypopharyngeal cancer mri in the news
Blogs on Hypopharyngeal cancer mri
Directions to Hospitals Treating Hypopharyngeal cancer
Risk calculators and risk factors for Hypopharyngeal cancer mri

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]

MRI

MRI has the ability to be superior to CT in local staging and assessing perineural spread however relatively long acquisition times and degradation by motion artefact are sometimes challenging 3.

T1: intermediate to low signal mass T2: intermediate to high signal T1 C+ (GAD): enhancement usually present larger tumours of nodal metastases may be centrally necrotic